|
|
Blood, 15 December 2007, Vol. 110, No. 13, pp. 4367-4369.
Prepublished online as a Blood First Edition Paper on September 18, 2007; DOI 10.1182/blood-2007-06-098244.
Previous Article | Table of Contents | Next Article 
IMMUNOBIOLOGY
Brief Report
Constitutively active STAT6 predisposes toward a lymphoproliferative disorder
Mark H. Kaplan1,
Sarita Sehra1,
Hua-Chen Chang1,
John T. O'Malley1,
Anubhav N. Mathur1, and
Heather A. Bruns2
1 Departments of Pediatrics and Microbiology and Immunology, Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN; and
2 Department of Biology, Ball State University, Muncie, IN
Signal transducer and activator of transcription 6 (STAT6) is critical for IL-4 and IL-13 responses, and necessary for the normal development of Th2 cells. We previously generated mice that express a constitutively active STAT6 (STAT6VT) under control of the CD2 locus control region, which directs expression to the T-cell compartment. We now describe that a small proportion of these mice ( 5%) develop a spontaneous lymphoproliferative disease (LPD) that results in dramatic splenomegaly. The cell populations observed in the LPD spleens can be divided into 2 categories, those that are composed of mixed lineage cells and those that are predominantly T cells with a phenotype similar to that in autoimmune lymphoproliferative syndrome (ALPS) patients. These data suggest that while active STAT6 is not a transforming factor, expression in T cells predisposes toward the development of lymphoproliferative disorders.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Yu, J. L. Moreno, J. P. Stains, and A. D. Keegan
Complex Regulation of Tartrate-resistant Acid Phosphatase (TRAP) Expression by Interleukin 4 (IL-4): IL-4 INDIRECTLY SUPPRESSES RECEPTOR ACTIVATOR OF NF-{kappa}B LIGAND (RANKL)-MEDIATED TRAP EXPRESSION BUT MODESTLY INDUCES ITS EXPRESSION DIRECTLY
J. Biol. Chem.,
November 20, 2009;
284(47):
32968 - 32979.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Ritz, C. Guiter, F. Castellano, K. Dorsch, J. Melzner, J.-P. Jais, G. Dubois, P. Gaulard, P. Moller, and K. Leroy
Recurrent mutations of the STAT6 DNA binding domain in primary mediastinal B-cell lymphoma
Blood,
August 6, 2009;
114(6):
1236 - 1242.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|